Molecular mechanisms of tigecycline-resistance among Enterobacterales
Frontiers in Cellular and Infection Microbiology · 09.04.2024 · 14
DOI: 10.3389/fcimb.2024.1289396 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 09.04.2024. Verfasst von Lukasz Korczak und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiological Diagnostics and Infectious Immunology, Medical University of Bialystok, Bialystok, Poland. Hauptthemen laut MEDLINE: Tigecycline, Anti-Bacterial Agents, Enterobacteriaceae. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The global emergence of antimicrobial resistance to multiple antibiotics has recently become a significant concern. Gram-negative bacteria, known for their ability to acquire mobile genetic elements such as plasmids, represent one of the most hazardous microorganisms. This phenomenon poses a serious threat to public health. Notably, the significance of tigecycline, a member of the antibiotic group glycylcyclines and derivative of tetracyclines has increased. Tigecycline is one of the last-resort antimicrobial drugs used to treat complicated infections caused by multidrug-resistant (MDR) bacteria, extensively drug-resistant (XDR) bacteria or even pan-drug-resistant (PDR) bacteria. The primary mechanisms of tigecycline resistance include efflux pumps’ overexpression, tet genes and outer membrane porins. Efflux pumps are crucial in conferring multi-drug resistance by expelling antibiotics (such as tigecycline by direct expelling) and decreasing their concentration to sub-toxic levels. This review discusses the problem of tigecycline resistance, and provides important information for understanding the existing molecular mechanisms of tigecycline resistance in Enterobacterales . The emergence and spread of pathogens resistant to last-resort therapeutic options stands as a major global healthcare concern, especially when microorganisms are already resistant to carbapenems and/or colistin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiological Diagnostics and Infectious Immunology, Medical University of Bialystok, Bialystok, Poland.
- Regional Centre for Transfusion Medicine, Bialystok, Poland.
Zitieren
APA
Korczak, L., Majewski, P., Iwaniuk, D., Sacha, P., Matulewicz, M., Wieczorek, P., Majewska, P., Wieczorek, A., Radziwon, P., & Tryniszewska, E. (2024). Molecular mechanisms of tigecycline-resistance among Enterobacterales. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1289396
Vancouver
Korczak L, Majewski P, Iwaniuk D, Sacha P, Matulewicz M, Wieczorek P, et al. Molecular mechanisms of tigecycline-resistance among Enterobacterales. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1289396
BibTeX
@article{Korczak2024,
author = {Korczak, Lukasz and Majewski, Piotr and Iwaniuk, Dominika and Sacha, Pawel and Matulewicz, Mariola and Wieczorek, Piotr and Majewska, Paulina and Wieczorek, Anna and Radziwon, Piotr and Tryniszewska, Elzbieta},
title = {Molecular mechanisms of tigecycline-resistance among Enterobacterales},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
volume = {14},
doi = {10.3389/fcimb.2024.1289396}
}
EUVIMED